190 related articles for article (PubMed ID: 31914034)
1. Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders: Study protocol of a double-blind randomized placebo-controlled trial.
Kang SJ; Cho HB; Jo EH; Yang GJ; Hong JE; Lee JH; Shim YH; Mun JH; Park MC
Medicine (Baltimore); 2020 Jan; 99(2):e18565. PubMed ID: 31914034
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Soshiho-tang in patients with atopic dermatitis and gastrointestinal disorders: Study protocol for a double-blind, randomized, and placebo-controlled clinical trial.
Kang SJ; Jo EH; Yang GJ; Shim YH; Hong JE; Park MC
Medicine (Baltimore); 2019 May; 98(18):e15479. PubMed ID: 31045830
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Soshiho-tang in atopic dermatitis patients with gastrointestinal disorders: A double-blinded, randomized, and placebo-controlled clinical trial.
Lee JH; Jo EH; Jung JY; Kang SJ; Yang GJ; Shim YH; Park MC
J Ethnopharmacol; 2021 Jun; 274():114006. PubMed ID: 33766759
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of an herbal formula, Gwakhyangjeonggi-san on atopic dermatitis with gastrointestinal symptoms: Protocol for a randomized controlled trial.
Son MJ; Kim MH; Kang M; Kim YE; Jung J; Choi I
Medicine (Baltimore); 2020 Jul; 99(28):e20675. PubMed ID: 32664064
[TBL] [Abstract][Full Text] [Related]
5. Topical application of Jaungo in atopic dermatitis patients: study protocol for a randomized, controlled trial.
Yun Y; Ko Y; Ahn JH; Jang BH; Kim K; Ko SG; Choi I
Trials; 2017 Apr; 18(1):176. PubMed ID: 28403910
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial.
Li YQ; Shen TT; Wang QY; Ma MX; Tian FY; She YY; Tao YC; Wang JJ; Chi HY; Lang N; Ren JX
Trials; 2022 May; 23(1):379. PubMed ID: 35534883
[TBL] [Abstract][Full Text] [Related]
7. A multicenter study on the efficacy and safety of So-Cheong-Ryong-Tang for perennial allergic rhinitis.
Kim MH; Hong SU; Kim HT; Seo HS; Kim K; Ko SG; Choi I
Complement Ther Med; 2019 Aug; 45():50-56. PubMed ID: 31331582
[TBL] [Abstract][Full Text] [Related]
8. The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.
Xuan M; Guo X; Li H; Xie T; Mo X; Wen Z
Trials; 2021 Jan; 22(1):67. PubMed ID: 33468222
[TBL] [Abstract][Full Text] [Related]
9. Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study.
Ahn JH; Yun Y; Kim MH; Ko SG; Kim KS; Choi I
Complement Ther Med; 2018 Oct; 40():22-28. PubMed ID: 30219454
[TBL] [Abstract][Full Text] [Related]
10. Effects of Bojungikgi-tang on anorexic patients with atopic dermatitis: A protocol for a randomized, usual care-controlled, assessor-blinded, parallel, pilot clinical trial.
Lee B; Park HJ; Jung SY; Kwon OJ; Ko MM; Jeong HA; Jung J
Medicine (Baltimore); 2022 Mar; 101(9):e28965. PubMed ID: 35244061
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Jujadokseo-hwan for memory deficit (amnesia) in mild neurocognitive disorder: A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial.
Jeong JH; Lee JY; Kim JY; Seo YK; Kang WC; Kang HW; Park SJ; Jang HK; Park YC; Jung IC
Medicine (Baltimore); 2020 Feb; 99(8):e19231. PubMed ID: 32080123
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial.
Gu SX; Zhang AL; Coyle ME; Mo X; Lenon GB; Cranswick NE; Chen D; Xue CC
Trials; 2015 Jul; 16():294. PubMed ID: 26149448
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study.
Wu YJ; Wu WF; Hung CW; Ku MS; Liao PF; Sun HL; Lu KH; Sheu JN; Lue KH
J Microbiol Immunol Infect; 2017 Oct; 50(5):684-692. PubMed ID: 26733351
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of Gwakhyangjeonggi-san for gastrointestinal complications in atopic dermatitis: A randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
Ko MM; Shin S; Kim MH; Kang M; Baek MG; Yi H; Son MJ; Jung J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117256. PubMed ID: 37778520
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a Chinese herbal medicine for the treatment of atopic dermatitis: a randomised controlled study.
Liu J; Mo X; Wu D; Ou A; Xue S; Liu C; Li H; Wen Z; Chen D
Complement Ther Med; 2015 Oct; 23(5):644-51. PubMed ID: 26365443
[TBL] [Abstract][Full Text] [Related]
17. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
Chan S; Cornelius V; Cro S; Harper JI; Lack G
JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Meysami M; Hashempur MH; Kamalinejad M; Emtiazy M
Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1673-1678. PubMed ID: 33100212
[TBL] [Abstract][Full Text] [Related]
19. Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial.
Lee KH; Lee HG; Kwon S; Park SU; Jung WS; Moon SK; Park JM; Ko CN; Cho SY
BMC Complement Med Ther; 2023 Oct; 23(1):375. PubMed ID: 37872506
[TBL] [Abstract][Full Text] [Related]
20. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial.
Tsianakas A; Luger TA; Radin A
Br J Dermatol; 2018 Feb; 178(2):406-414. PubMed ID: 28845523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
